Brussels, 13/06/2016 (Agence Europe) - The European Commission has been walking on eggshells in the sensitive dossier on endocrine disruptors. On Wednesday 15 June, it is expected to propose that it draw on the WHO/IPCS criteria to define - and ultimately prohibit - substances that alter the endocrine system. This approach does, therefore, not take into account the potency of an agent (the link between the dose and the effect) as supported by the industry or the "potential" disruptors that...